Potent antitumor activity of cabozantinib, a c‐MET and VEGFR 2 inhibitor, in a colorectal cancer patient‐derived tumor explant model
Abstract
Antiangiogenic therapy is commonly used for the treatment of colorectal cancer (CRC). Although patients derive some clinical benefit, treatment resistance inevitably occurs. The MET signaling pathway has been proposed to be a major contributor of resistance to antiangiogenic therapy. MET is upregulated in response to vascular endothelial growth factor pathway inhibition and plays an essential role in tumorigenesis and progression of tumors. In...
Paper Details
Title
Potent antitumor activity of cabozantinib, a c‐MET and VEGFR 2 inhibitor, in a colorectal cancer patient‐derived tumor explant model
Published Date
Sep 29, 2014
Volume
136
Issue
8
Pages
1967 - 1975
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History